- Mayke B G Koek, research fellow dermatology1,
- Erik Buskens, professor of medical technology assessment2,
- Carla AFM Bruijnzeel-Koomen, professor of dermatology/allergology1,
- Vigfús Sigurdsson, dermatologist1
- 1University Medical Centre Utrecht, 3584 CX Utrecht, Netherlands
- 2Department of Epidemiology, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands
- author{at}koek.com
Cameron and Dawe suggest that careful selection of patients is essential to maintain and safeguard efficacy and safety, seeming to think that patients in our trial were also specifically selected.1 However, our patients were a representative sample of those considered clinically eligible. …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: How much of a social media profile can doctors have?
Published 13 February 2012
Re: Diagnosis and management of Raynaud’s phenomenon
Published 13 February 2012
Re: Is it unethical for doctors to encourage healthy adults to donate a kidney to a stranger? No
Published 13 February 2012
Re: Report predicts 20 million AIDS orphans in Africa by 2010
Published 13 February 2012
Re: On the impossibility of being expert
Published 13 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (8 responses)
Published 27 Jan 2012
How much of a social media profile can doctors have? (7 responses)
Published 23 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012